Free Research Preview

AI Tumor Board for Oncology

Paste a de-identified case and watch nine specialist AI agents research it against live PubMed and ClinicalTrials.gov evidence, debate across rounds, and deliver a citation-grounded consensus recommendation — in about five minutes.

0 / 10,000 characters

Try a synthetic sample:

AML, FLT3-ITD
NSCLC, EGFR exon 19
Early HR+ breast cancer

City + state/country — filters trial matches to nearby sites

For research and education only — not medical advice. AI output may be wrong or incomplete.

Cases are processed in memory only and are not stored after your session ends (sessions expire within 30 minutes). Case text is sent to a third-party AI provider (OpenAI) and to public biomedical databases (PubMed, ClinicalTrials.gov, and similar) to retrieve evidence. See our Privacy Policy.

How it works

1 · Triage

A router reads your case and convenes only the relevant specialists — the pharmacist safety gate is always on.

2 · Research & debate

Each agent searches live biomedical sources and drafts a recommendation where every clinical claim must carry a citation. A judge scores consensus and opens a second round when the panel disagrees.

3 · Consensus report

A synthesizer writes the final recommendation with a deduplicated, linked evidence list — fabricated citations are structurally impossible.

Who's on the panel

MO

Medical Oncologist

Guideline-first systemic therapy, checked against recent FDA approvals.

He

Hematologist

Disease lead for leukemia, lymphoma, myeloma, MDS, and heme emergencies.

RO

Radiation Oncologist

Target, intent, dose/fractionation, and sequencing when RT has a role.

SO

Surgical Oncologist

Resectability, approach, and palliative or oligometastatic procedures.

Rx

Clinical Pharmacist

Always-on medication safety gate: interactions, dosing, monitoring.

MX

Molecular Oncologist

Biomarkers to targeted therapy and trials, grounded in CIViC evidence.

Pa

Pathologist

Adjudicates diagnostic ambiguity — equivocal IHC, NOS, 'favor' calls.

Tx

Transplant / Cellular Therapy

When and how HSCT or CAR-T enters, with an eligibility readout.

CT

Clinical Trial Matcher

Screens ClinicalTrials.gov criteria, filtered to nearby sites.

Frequently asked questions

How does the AI Tumor Board work?

A triage step convenes the relevant specialist AI agents for your case. Each agent independently searches live biomedical sources (PubMed, ClinicalTrials.gov, FDA labels, CIViC and more), drafts a recommendation in which every clinical claim must carry a citation, and a judge scores consensus across discussion rounds before a final synthesized recommendation is produced.

Is this medical advice?

No. The AI Tumor Board is a research and educational demonstration. Its output is AI-generated, is not reviewed by a physician, and must never be used to make treatment decisions. Always consult qualified clinicians and your institutional tumor board.

Is my case stored?

No accounts and no persistent storage: cases are processed in memory and expire within 30 minutes. Case text is sent to a third-party AI provider and to public biomedical databases to retrieve evidence, so never include real patient identifiers.

For research and education only — not medical advice. AI output may be wrong or incomplete.